Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

63%

5 of 8 completed trials have results

Key Signals

2 recruiting5 with results

Enrollment Performance

Analytics

N/A
8(80.0%)
Phase 2
1(10.0%)
Early Phase 1
1(10.0%)
10Total
N/A(8)
Phase 2(1)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)